University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 13 of 18
Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
NCT01738243
Delivery of Anxiety Disorder Treatment in Addictions Centers
NCT01764698
Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode
NCT02267070
Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial
NCT01966679
Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)
NCT01953120
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
NCT02597790
Brain Aging and Treatment Response in Geriatric Depression
NCT01902004
Whole Coffee Fruit Concentrate Pilot Study 1
NCT01965795
Yoga Training for Returning Veterans With Headache
NCT01993069
Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive Impairment
NCT01983930
Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels
NCT01944904
Heart Failure Caregiver Study
NCT01937936
Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene
NCT01852071
UCLA Fitness and Memory Study of Activity In Mild Cognitive Impairment (AIM)
NCT02001441
Generalization of Extinction Learning
NCT01900301
Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves
NCT02119442
Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes
NCT02733172
Trial of Ibudilast for Methamphetamine Dependence
NCT01860807
Perineal Self-Acupressure
NCT01867944
A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
NCT01781806
Salivary Biomarkers for Sjögren's Syndrome Detection
NCT01807689
Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women
NCT01889199
An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents
NCT01825694
Attention Training for Childhood Obsessive Compulsive Disorder
NCT02114918
Field Administration of Stroke Therapy-Blood Pressure Lowering
NCT01811693
Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings
NCT01883791
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
NCT02003183
"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
NCT01694433
Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization
NCT01778855
Neuroimaging and Biomarkers in Chronic Visceral Pain
NCT01602575
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
NCT01751698
Cannabis Effects on Brain Morphology in Aging
NCT01874886
Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation
NCT01714310
Neural and Physiological Responses to Real-World Experiences
NCT01723410
Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
NCT01874327
Effects of Omega-3 Fatty Acid Supplementation in Acne Patients
NCT01764308
Cell Phone Technology Targeting ART Adherence and Drug Use
NCT01884233
Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
NCT01457066
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
NCT01406626
Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series
NCT01708226
Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?
NCT01737593
Building Resiliency and Increasing Community Hope
NCT01698047
Home Visiting for Low Income, Pregnant Women
NCT01687634
Neuropharmacological Basis of Social Connection: The Role of Opioids
NCT01672723
Neuropeptides and Social Behavior
NCT01680718
Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders
NCT02150681
Adoption-specific Treatment Prevention Pilot Trial
NCT01744951
Plan A Birth Control: Randomized Controlled Trial of a Mobile Health Application for Contraception Information
NCT02234271
mFit: The Mobile Fitness Project
NCT01650337
A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease
NCT01578772
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.